LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

An in vitro cytotoxicities comparison of 16 priority polycyclic aromatic hydrocarbons in human pulmonary alveolar epithelial cells HPAEpiC.

Photo from archive.org

In present study, we compared for the first time the cytotoxicities of the 16 priority polycyclic aromatic hydrocarbons (PAHs) in human pulmonary alveolar epithelial cells HPAEpiC. Moreover, we examined the… Click to show full abstract

In present study, we compared for the first time the cytotoxicities of the 16 priority polycyclic aromatic hydrocarbons (PAHs) in human pulmonary alveolar epithelial cells HPAEpiC. Moreover, we examined the effects of each PAH on oxidative stress (SOD, GSH, and ROS), cell viability, extracellular LDH, and apoptosis. The 16 priority PAHs were classified into four levels of cytotoxicity: (1) high cytotoxicity, BkF, BaP, and DBA; (2) moderate cytotoxicity, BbF, IND, BghiP, BaA, and CHR; (3) low cytotoxicity, PA, FL, and Pyr; and (4) mild cytotoxicity, Nap, AcPy, Acp, Flu, and Ant. Most of the PAHs showed benzene-ring-related cytotoxicity, except PA with 3-ring structure, cytotoxicity of which is similar to those of FL and Pyr with 4-ring structure. Results indicated the need for more studies on DBA, IND, and BghiP, among others, which are rarely investigated. PA, FL, and Pyr with little carcinogenicity should also be evaluated. This study will provide useful references for studies on the effects of PAHs on different cells or animal models.

Keywords: pulmonary alveolar; priority polycyclic; aromatic hydrocarbons; human pulmonary; polycyclic aromatic; cytotoxicity

Journal Title: Toxicology letters
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.